Bisphosphonates - the first line treatment for osteoporosis or osteopenia - Video

As per WHO records 14.5% men suffer from osteoporosis and 18% in women and it is highly prevalent in menopausal women. Bisphosphonates are known to prevent bone loss in both osteoporosis and osteopenia.

Bisphosphonates can be recommended as a first-line treatment for the prevention and treatment of osteoporosis and can decrease the risk of hip fracture among the general population, according to a recent study published in the BMJ Journal.

This meta-analysis and systematic review investigated the efficacy of bisphosphonates on the incidence of hip fracture (IHF) in patients of different ages with osteoporosis or osteopenia. They reviewed trials reporting the effects of bisphosphonates on the incidence of hip fracture (IHF). The double blinded placebo trial found that there was biphosphonates reduced IHF in all age groups. The researchers pooled data using a random-effects meta-analysis with risk ratios (RRs) and reported 95% CIs.

For more information check out the full story on the link below:

Bisphosphonates effective as first-line treatment for osteoporosis or ostopenia: Study